Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization
José F. Varona, Pedro Landete, View ORCID ProfileJose A. Lopez-Martin, Vicente Estrada, Roger Paredes, Pablo Guisado-Vasco, Lucía Fernández de Orueta, Miguel Torralba, Jesús Fortún, Roberto Vates, José Barberán, Bonaventura Clotet, Julio Ancochea, Daniel Carnevali, Noemí Cabello, Lourdes Porras, Paloma Gijón, Alfonso Monereo, Daniel Abad, Sonia Zúñiga, Isabel Sola, Jordi Rodon, Nuria Izquierdo-Useros, Salvador Fudio, María José Pontes, Beatriz de Rivas, Patricia Girón de Velasco, Belén Sopesén, Antonio Nieto, Javier Gómez, Pablo Avilés, Rubin Lubomirov, Kris M. White, Romel Rosales, Soner Yildiz, Ann-Kathrin Reuschl, Lucy G. Thorne, Clare Jolly, Greg J. Towers, Lorena Zuliani-Alvarez, Mehdi Bouhaddou, Kirsten Obernier, Luis Enjuanes, Jose M. Fernández-Sousa, Plitidepsin – COVID - 19 Study Group, Nevan J. Krogan, José M. Jimeno, Adolfo García-Sastre
doi: https://doi.org/10.1101/2021.05.25.21257505
José F. Varona
1Departamento de Medicina Interna, Hospital Universitario HM Monteprincipe, HM Hospitales, Madrid, Spain
2Facultad de Medicina, Universidad San Pablo-CEU, Madrid, Spain
Pedro Landete
3Hospital Universitario La Princesa, Madrid, Spain
4Universidad Autónoma de Madrid, Madrid, Spain
Jose A. Lopez-Martin
5Virology & Inflammation Unit, PharmaMar, S.A., Colmenar Viejo, Madrid, Spain
Vicente Estrada
6Hospital Clínico San Carlos, Madrid, Spain
7Universidad Complutense de Madrid, Madrid, Spain
Roger Paredes
8Infectious Diseases Department, irsiCaixa AIDS Research Institute, Badalona, Barcelona, Spain
9Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain
Pablo Guisado-Vasco
10Internal Medicine Department. Hospital Universitario Quironsalud Madrid, Madrid, Spain
11Universidad Europea, Madrid, Spain
Lucía Fernández de Orueta
11Universidad Europea, Madrid, Spain
12Internal Medicine Department, Hospital Universitario de Getafe, Madrid, Spain
Miguel Torralba
13Health Sciences Faculty, University of Alcalá, Madrid, Spain
14Guadalajara University Hospital, Guadalajara, Spain
Jesús Fortún
15Hospital Universitario Ramón y Cajal, Madrid, Spain
Roberto Vates
12Internal Medicine Department, Hospital Universitario de Getafe, Madrid, Spain
José Barberán
1Departamento de Medicina Interna, Hospital Universitario HM Monteprincipe, HM Hospitales, Madrid, Spain
2Facultad de Medicina, Universidad San Pablo-CEU, Madrid, Spain
Bonaventura Clotet
8Infectious Diseases Department, irsiCaixa AIDS Research Institute, Badalona, Barcelona, Spain
9Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain
16Universitat Autònoma de Barcelona, Barcelona, Spain
17Universitat de Vic, Universitat Central de Catalunya Barcelona, Spain
Julio Ancochea
3Hospital Universitario La Princesa, Madrid, Spain
4Universidad Autónoma de Madrid, Madrid, Spain
18Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid
Daniel Carnevali
10Internal Medicine Department. Hospital Universitario Quironsalud Madrid, Madrid, Spain
11Universidad Europea, Madrid, Spain
Noemí Cabello
19Infectious Diseases Department, Clinico San Carlos University Hospital, Madrid, Spain
Lourdes Porras
20Internal Medicine, Hospital General de Ciudad Real, Ciudad Real, Spain
Paloma Gijón
21Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
Alfonso Monereo
12Internal Medicine Department, Hospital Universitario de Getafe, Madrid, Spain
Daniel Abad
11Universidad Europea, Madrid, Spain
12Internal Medicine Department, Hospital Universitario de Getafe, Madrid, Spain
Sonia Zúñiga
22Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain
Isabel Sola
22Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain
Jordi Rodon
23IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Campus de la UAB, Bellaterra, Spain
Nuria Izquierdo-Useros
24IrsiCaixa AIDS Research Institute, Badalona, Barcelona, Spain
25Germans Trias i Pujol Research Institute (IGTP), Badalona, Barcelone, Spain
Salvador Fudio
26Clinical Pharmacology Unit, PharmaMar, Colmenar Viejo, Madrid, Spain
María José Pontes
27Medical Affairs, PharmaMar, Colmenar Viejo, Madrid, Spain
Beatriz de Rivas
27Medical Affairs, PharmaMar, Colmenar Viejo, Madrid, Spain
Patricia Girón de Velasco
5Virology & Inflammation Unit, PharmaMar, S.A., Colmenar Viejo, Madrid, Spain
Belén Sopesén
5Virology & Inflammation Unit, PharmaMar, S.A., Colmenar Viejo, Madrid, Spain
28Sylentis, S.A.U., Tres Cantos, Madrid, Spain
29Biocross, S.L., Valladolid, Spain
Antonio Nieto
30Bio Statistics Unit, PharmaMar, Colmenar Viejo, Madrid, Spain
Javier Gómez
30Bio Statistics Unit, PharmaMar, Colmenar Viejo, Madrid, Spain
Pablo Avilés
31Preclinical Unit, Pharmamar, Colmenar Viejo, Madrid, Spain
Rubin Lubomirov
26Clinical Pharmacology Unit, PharmaMar, Colmenar Viejo, Madrid, Spain
Kris M. White
32Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
33Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Romel Rosales
32Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
33Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Soner Yildiz
32Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
33Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Ann-Kathrin Reuschl
34Division of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom
Lucy G. Thorne
34Division of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom
Clare Jolly
34Division of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom
Greg J. Towers
34Division of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom
Lorena Zuliani-Alvarez
35Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA
36J. David Gladstone Institutes, San Francisco, CA 94158, USA
37Quantitative Biosciences Institute (QBI), Coronavirus Research Group (QCRG), San Francisco, CA 94158, USA
38Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94518, USA
Mehdi Bouhaddou
35Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA
36J. David Gladstone Institutes, San Francisco, CA 94158, USA
37Quantitative Biosciences Institute (QBI), Coronavirus Research Group (QCRG), San Francisco, CA 94158, USA
38Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94518, USA
Kirsten Obernier
35Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA
36J. David Gladstone Institutes, San Francisco, CA 94158, USA
37Quantitative Biosciences Institute (QBI), Coronavirus Research Group (QCRG), San Francisco, CA 94158, USA
38Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94518, USA
Luis Enjuanes
22Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain
Jose M. Fernández-Sousa
39Pharmamar, Colmenar Viejo, Madrid, Spain
Nevan J. Krogan
32Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
35Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA 94158, USA
36J. David Gladstone Institutes, San Francisco, CA 94158, USA
37Quantitative Biosciences Institute (QBI), Coronavirus Research Group (QCRG), San Francisco, CA 94158, USA
38Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94518, USA
José M. Jimeno
5Virology & Inflammation Unit, PharmaMar, S.A., Colmenar Viejo, Madrid, Spain
Adolfo García-Sastre
32Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
33Global Health Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
40Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA
41Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Data Availability
Plitidepsin is available from PharmaMar for noncommercial use under an MTA. All relevant data are included within this manuscript and all materials other than plitidepsin are readily available upon request from the corresponding authors.
Posted May 25, 2021.
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization
José F. Varona, Pedro Landete, Jose A. Lopez-Martin, Vicente Estrada, Roger Paredes, Pablo Guisado-Vasco, Lucía Fernández de Orueta, Miguel Torralba, Jesús Fortún, Roberto Vates, José Barberán, Bonaventura Clotet, Julio Ancochea, Daniel Carnevali, Noemí Cabello, Lourdes Porras, Paloma Gijón, Alfonso Monereo, Daniel Abad, Sonia Zúñiga, Isabel Sola, Jordi Rodon, Nuria Izquierdo-Useros, Salvador Fudio, María José Pontes, Beatriz de Rivas, Patricia Girón de Velasco, Belén Sopesén, Antonio Nieto, Javier Gómez, Pablo Avilés, Rubin Lubomirov, Kris M. White, Romel Rosales, Soner Yildiz, Ann-Kathrin Reuschl, Lucy G. Thorne, Clare Jolly, Greg J. Towers, Lorena Zuliani-Alvarez, Mehdi Bouhaddou, Kirsten Obernier, Luis Enjuanes, Jose M. Fernández-Sousa, Plitidepsin – COVID - 19 Study Group, Nevan J. Krogan, José M. Jimeno, Adolfo García-Sastre
medRxiv 2021.05.25.21257505; doi: https://doi.org/10.1101/2021.05.25.21257505
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization
José F. Varona, Pedro Landete, Jose A. Lopez-Martin, Vicente Estrada, Roger Paredes, Pablo Guisado-Vasco, Lucía Fernández de Orueta, Miguel Torralba, Jesús Fortún, Roberto Vates, José Barberán, Bonaventura Clotet, Julio Ancochea, Daniel Carnevali, Noemí Cabello, Lourdes Porras, Paloma Gijón, Alfonso Monereo, Daniel Abad, Sonia Zúñiga, Isabel Sola, Jordi Rodon, Nuria Izquierdo-Useros, Salvador Fudio, María José Pontes, Beatriz de Rivas, Patricia Girón de Velasco, Belén Sopesén, Antonio Nieto, Javier Gómez, Pablo Avilés, Rubin Lubomirov, Kris M. White, Romel Rosales, Soner Yildiz, Ann-Kathrin Reuschl, Lucy G. Thorne, Clare Jolly, Greg J. Towers, Lorena Zuliani-Alvarez, Mehdi Bouhaddou, Kirsten Obernier, Luis Enjuanes, Jose M. Fernández-Sousa, Plitidepsin – COVID - 19 Study Group, Nevan J. Krogan, José M. Jimeno, Adolfo García-Sastre
medRxiv 2021.05.25.21257505; doi: https://doi.org/10.1101/2021.05.25.21257505
Subject Area
Subject Areas
- Addiction Medicine (379)
- Allergy and Immunology (694)
- Anesthesia (186)
- Cardiovascular Medicine (2806)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12491)
- Forensic Medicine (10)
- Gastroenterology (795)
- Genetic and Genomic Medicine (4359)
- Geriatric Medicine (397)
- Health Economics (710)
- Health Informatics (2805)
- Health Policy (1041)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (410)
- Medical Ethics (113)
- Nephrology (458)
- Neurology (4126)
- Nursing (219)
- Nutrition (612)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (315)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (478)
- Public and Global Health (6719)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)